Patents by Inventor Lawrence M. Deyoung

Lawrence M. Deyoung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimized multi-epitope constructs and uses thereof
    Patent number: 7888472
    Abstract: The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: February 15, 2011
    Assignees: Epimmune Inc., GENimmune N.V.
    Inventors: Alessandro Sette, Robert Chesnut, Mark J. Newman, Brian D. Livingston, Lilia Maria Babe, Yiyou Chen, Lawrence M. Deyoung, Manley T. F. Huang, Scott D. Power
  • Optimized Multi-Epitope Constructs and Uses Thereof
    Publication number: 20100068218
    Abstract: The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.
    Type: Application
    Filed: March 20, 2009
    Publication date: March 18, 2010
    Inventors: Alessandro SETTE, Robert Chesnut, Mark J. Newman, Brian D. Livingston, Lilia Marie Babe, Yiyou Chen, Lawrence M. Deyoung, Manley T.F. Huang, Scott D. Power
  • Optimized multi-epitope constructs and uses thereof
    Patent number: 7507803
    Abstract: The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: March 24, 2009
    Assignee: Genimmune N.V.
    Inventors: Alessandro Sette, Robert Chesnut, Mark J. Newman, Brian D. Livingston, Lilia Maria Babe, Yiyou Chen, Lawrence M. Deyoung, Manley T. F. Huang, Scott D. Power
  • Transglutaminase inhibitors
    Patent number: 4929630
    Abstract: The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transglutaminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
    Type: Grant
    Filed: September 8, 1989
    Date of Patent: May 29, 1990
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Arlindo L. Castelhano, Lawrence M. DeYoung, Alexander Krantz, Diana H. Pliura, Michael C. Venuti
  • 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
    Patent number: 4912120
    Abstract: The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transgulatminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
    Type: Grant
    Filed: March 13, 1987
    Date of Patent: March 27, 1990
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Arlindo L. Castelhano, Lawrence M. DeYoung, Alexander Krantz, Diana H. Pliura, Michael C. Venuti